Publications
-
Sequential azacitidine plus lenalidomide combination for elderly patients with untreated acute myeloid leukemia.
Pollyea DA,
Zehnder J, Coutre S, Gotlib JR, Gallegos L, Abdel-Wahab O, Greenberg P, Zhang B, Liedtke M, Berube C, Levine R, Mitchell BS, Medeiros BC.
Haematologica.
2013;
98
(4):
591-6
-
Blood consult: monosomal karyotype acute myeloid leukemia.
Garcia JS,
Medeiros BC, Appelbaum FR.
Blood.
2012;
119
(24):
5659-60
-
Impact of body-mass index on the outcome of adult patients with acute myeloid leukemia.
Medeiros BC,
Othus M, Estey EH, Fang M, Appelbaum FR.
Haematologica.
2012;
97
(9):
1401-4
-
Impact of residual normal metaphases in core binding factor acute myeloid leukemia.
Medeiros BC,
Othus M, Fang M, Appelbaum FR, Estey EH.
Cancer.
2012;
118
(9):
2420-3
-
Safety, efficacy and biological predictors of response to sequential azacitidine and lenalidomide for elderly patients with acute myeloid leukemia.
Pollyea DA,
Kohrt HE, Gallegos L, Figueroa ME, Abdel-Wahab O, Zhang B, Bhattacharya S, Zehnder J, Liedtke M, Gotlib JR, Coutre S, Berube C, Melnick A, Levine R, Mitchell BS, Medeiros BC.
Leukemia.
2012;
26
(5):
893-901
-
Tailored temozolomide therapy according to MGMT methylation status for elderly patients with acute myeloid leukemia.
Medeiros BC,
Kohrt HE, Gotlib J, Coutre SE, Zhang B, Arber DA, Zehnder JL.
Am J Hematol.
2012;
87
(1):
45-50
-
Unveiling the complexity of CK+ AML.
Medeiros BC,
Blood.
2012;
119
(9):
1958-9
-
Cytarabine dose for acute myeloid leukemia.
Medeiros BC,
Othus M, Appelbaum FR.
N Engl J Med.
2011;
364
(22):
2167-8; author reply 2168-9
-
Prognostic impact of monosomal karyotype in young adult and elderly acute myeloid leukemia: the Southwest Oncology Group (SWOG) experience.
Medeiros BC,
Othus M, Fang M, Roulston D, Appelbaum FR.
Blood.
2010;
116
(13):
2224-8
-
2-Hydroxyglutarate in IDH mutant acute myeloid leukemia: predicting patient responses, minimal residual disease and correlations with methylcytosine and hydroxymethylcytosine levels.
Pollyea DA,
Kohrt HE, Zhang B, Zehnder J, Schenkein D, Fantin V, Straley K, Vasanthakumar A, Abdel-Wahab O, Levine R, Godley LA, Medeiros BC.
Leuk Lymphoma.
2013;
54
(2):
408-10
-
A single-center experience of the nationwide daunorubicin shortage: substitution with doxorubicin in adult acute lymphoblastic leukemia.
Patel S,
Liedtke M, Ngo D, Medeiros BC.
Leuk Lymphoma.
2013
-
CD11b expression and MK+ AML: a sign of impending doom?
Medeiros BC,
Leuk Res.
2013;
37
(2):
121
-
"It doesn't matter if you're black or white", does it?
Medeiros BC,
Leuk Res.
2012;
36
(2):
127
-
Aggressive EBV-associated lymphoproliferative disorder: a prodrome to diffuse large B-cell lymphoma?
Batra R,
Medeiros BC, Zehnder JL, Warnke RA, Natkunam Y.
Appl Immunohistochem Mol Morphol.
2012;
20
(3):
325-30
-
CD19-CD45 low/- CD38 high/CD138+ plasma cells enrich for human tumorigenic myeloma cells.
Kim D,
Park CY, Medeiros BC, Weissman IL.
Leukemia.
2012;
26
(12):
2530-7
-
Novel agents in acute myeloid leukemia.
Ungewickell A,
Medeiros BC.
Int J Hematol.
2012;
96
(2):
178-85
-
Phase I trial of a novel human monoclonal antibody mAb216 in patients with relapsed or refractory B-cell acute lymphoblastic leukemia.
Liedtke M,
Twist CJ, Medeiros BC, Gotlib JR, Berube C, Bieber MM, Bhat NM, Teng NN, Coutre SE.
Haematologica.
2012;
97
(1):
30-7
-
Phase II trial of vorinostat and gemtuzumab ozogamicin as induction and post-remission therapy in older adults with previously untreated acute myeloid leukemia.
Walter RB,
Medeiros BC, Powell BL, Schiffer CA, Appelbaum FR, Estey EH.
Haematologica.
2012;
97
(5):
739-42
-
Treatment advances have not improved the early death rate in acute promyelocytic leukemia.
McClellan JS,
Kohrt HE, Coutre S, Gotlib JR, Majeti R, Alizadeh AA, Medeiros BC.
Haematologica.
2012;
97
(1):
133-6
-
Acute myeloid leukaemia in the elderly: a review.
Pollyea DA,
Kohrt HE, Medeiros BC.
Br J Haematol.
2011;
152
(5):
524-42
-
Microfluidic purification and analysis of hematopoietic stem cells from bone marrow.
Schirhagl R,
Fuereder I, Hall EW, Medeiros BC, Zare RN.
Lab Chip.
2011;
11
(18):
3130-5
-
Unfavorable-risk cytogenetics in acute myeloid leukemia.
Hong WJ,
Medeiros BC.
Expert Rev Hematol.
2011;
4
(2):
173-84
-
Immunophenotypic features of acute myeloid leukemia with inv(3)(q21q26.2)/t(3;3)(q21;q26.2).
Medeiros BC,
Kohrt HE, Arber DA, Bangs CD, Cherry AM, Majeti R, Kogel KE, Azar CA, Patel S, Alizadeh AA.
Leuk Res.
2010;
34
(5):
594-7
-
Myelomastocytic leukemia versus mast cell leukemia versus systemic mastocytosis associated with acute myeloid leukemia: a diagnostic challenge.
Arredondo AR,
Gotlib J, Shier L, Medeiros B, Wong K, Cherry A, Corless C, Arber DA, Valent P, George TI.
Am J Hematol.
2010;
85
(8):
600-6
-
Plasma cell leukemia: concepts and management.
Liedtke M,
Medeiros BC.
Expert Rev Hematol.
2010;
3
(5):
543-9
-
Second-line mitoxantrone, etoposide, and cytarabine for acute myeloid leukemia: a single-center experience.
Kohrt HE,
Patel S, Ho M, Owen T, Pollyea DA, Majeti R, Gotlib J, Coutre S, Liedtke M, Berube C, Alizadeh AA, Medeiros BC.
Am J Hematol.
2010;
85
(11):
877-81
-
Comparing apples and oranges in normal karyotype acute myeloid leukemia.
Medeiros BC,
J Clin Oncol.
2009;
27
(3):
474; author reply 474-6
-
Complete remission of primary plasma cell leukemia with bortezomib, doxorubicin, and dexamethasone: a case report.
Chan SM,
George T, Cherry AM, Medeiros BC.
Cases J.
2009;
2
(1):
121
-
Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia.
Medeiros BC,
N Engl J Med.
2009;
360
(17):
1787; author reply 1787-8
-
Role of CEBPA in normal karyotype acute myeloid leukemia.
Medeiros BC,
J Clin Oncol.
2009;
27
(12):
2105; author reply 2106
-
Thalidomide-induced pneumonitis in a patient with plasma cell leukemia: No recurrence with subsequent lenalidomide therapy.
Pretz J,
Medeiros BC.
Am J Hematol.
2009;
84
(10):
698-9
Navigation for This Section: Hematology
Find a Researcher
Help